Antibodies againts phospholipid/cofactors. What to search for, when, why, and how ? Is treatment justified ?;Anticorps antiphospholipides/co-facteurs Qui sont-ils ? Pourquoi, quand et comment les rechercher ? Justifient-ils un traitement ?

Annales de Medecine Interne

Volumn 147, Issue 7, 1996, Pages 492-497

  Piette, Jean Charles ^a   Papo, Thomas ^a   Amoura, Zahir ^a   Boffa, Marie Claire ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Anti cardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Lupus anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; THROMBOSIS;

EID: 0030464668     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. LOVE PE, SANTORO SA : Antiphospholipid antibodies : anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990 ; 112 : 682-98.
2. KANDIAH DA, KRILIS SA : Immunology and methods of detection of antiphospholipid antibodies. In : ASHERSON RA, CERVERA R, PIETTE JC, SHOENFELDY, Ed. The antiphospholipid syndrome. Boca Raton : CRC Press, 1996 : 29-48.
3. PIETTE JC : 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome : a « mission impossible » ? Lupus 1996 ; 5 : 354-63.
4. HARRIS EN, BAGULEY E, ASHERSON RA, HUGHES GRV : Clinical and serological features of the « antiphospholipid syndrome ». Br J Rheumatol 1987 ; 26 (Suppl 2) : 19.
5. ASHERSON RA : A « primary » antiphospholipid syndrome ? J Rheumatol 1988 ; 15 : 1742-6.
6. ASHERSON RA, KHAMASHTA MA, ORDI-ROD J et al : The « primary » antiphospholipid syndrome : major clinical and serological features. Medicine 1989 ; 68 : 366-74.
7. KARMOCHKINE M, PIETTE JC, MAZOYER E et al : Anticorps antiphospholipides : cause des thromboses ou épiphénomène ? Presse Med 1995 ; 24 : 267-70.
8. DUEYMES M, PIETTE JC, LE TONQUEZE M et al : Role of β2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune disease. Lupus 1995 ; 4 : 477-81.
9. ROUBEY RAS : Autoantibodies to phospholipid-binding plasma proteins : a new view of lupus anticoagulants and other antiphospholipid autoantibodies. Blood 1994 ; 84 : 2854-67.
10. OOSTING JD, DERKSEN RHWM, BOBBINK IWG, HACKENG TM, BOUMA BN, de GROOT PG : Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S : an explanation for their pathogenic mechanism ? Blood 1993 ; 81 : 2618-25.
11. SUGI T, MCINTYRE JA : Autoantidodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995 ; 86 : 3083-9.
12. VIARD JP, AMOURA Z, BACH JF : Association of anti-ß2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992 ; 93 : 181-6.
13. CABIEDES J, CABRAL AR, ALARCON-SEGOVIA D : Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta(2)-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995 ; 22 : 1899-906.
14. CABRAL AR, CABIEDES J, ALARCON-SEGOVIA D : Antibodies to phospholipid-free b2-glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol 1995 ; 22 : 1894-8.
15. MCNALLY T, PURDY G, MACKIE IJ, MACHIN SJ, ISENBERG DA : The use of an anti-ß2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995 ; 91 : 71-3.
16. ALARCON-SEGOVIA D, CABRAL AR : The antiphospholipid/cofactors syndromes. J Rheumatol 1996 ; 23 : 1319-22.
17. ANTIPHOSPHOLIPID ANTIBODIES IN STROKE STUDY GROUP : Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993 ; 43 : 2069-73.
18. GINSBURG KS, LIANG MH, NEWCOMER L ét al : Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992 ; 117 : 997-1002.
19. VAARALA O, MÄNTTÄRI M, MANNINEN V et al : Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995 ; 91 : 23-7.
20. PIERANGELI SS, BARKER JH, STIKOVAC D et al : Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994 ; 71 : 670-4.
21. BAKIMER R, SHOENFELD Y : Pathogenesis of the antiphospholipid syndrome, in : ASHERSON RA, CERVERA R, PIETTE JC, SHOENFELD Y, eds, The antiphospholipid syndrome, Boca Raton : CRC Press, 1996 : 59-70.
22. BOFFA MC, PIETTE JC : Anticorps antiphospholipides : Recommandations Paris-1995. Nouv Rev Fr Hematol 1995 ; 37(Suppl II) : S117-S120.
23. BRANDT JT, BARNA LK, TRIPLETT DA : Laboratory identification of lupus anticoagulants : Results of the Second International Workshop for identification of lupus anticoagulants. Thromb Haemost 1995 ; 74 : 1597-603.
24. REBER G, DE MOERLOOSE P : Standardisation du dosage des anticorps anticardiolipine : douze ans après. STV 1995 ; 7 : 659-61.
25. LAROCHE P, BERARD M, ROUQUETTE AM, DESGRUELLE C, BOFFA MC : Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies. Am J Clin Pathol 1996 ; 106 : 549-54.
26. BIOUSSE V, PIETTE JC : Genetic aspects of the primary antiphospholipid syndrome. Nouv Rev Fr Hematol 1995 ; 37 (Suppl II) : S65-S67.
27. BRANCH DW : Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994 ; 3 : 275-80.
28. BOFFA MC, PIETTE JC : Questions-answers about antiphospholipid-protein antibodies and the antiphospholipid antibody syndrome. Ann Med Interne 1996 ; 147 (Suppl I) : 54-6.
29. FRANCES C, PIETTE JC, VIARD JP, TOURBAH A : Anti-ß2o glycoprotein I in Sneddon's syndrome. Dermatology 1993 ; 186 : 273.
30. PIETTE JC, PIETTE AM : Management of the antiphospholipid syndrome : main trends, unsolved questions, practical and educational aspects. Ann Med Interne 1996 ; 147 (Suppl I) : 28-31.
31. ROSOVE MH, BREWER PMC : Antiphospholipid thrombosis : clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992 ; 117 : 303-8.
32. KHAMASHTA MA, CUADRADO MJ, MUJIC F, TAUB NA, HUNT BJ, HUGHES GRV : The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995 ; 332 : 993-7.
33. FINAZZI G, BRANCACCIO V, MOIA M et al : Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies : a four-year prospective study from the Italian registry. Am J Med 1996 ; 100 : 530-6.
34. COWCHOCK FS, REECE EA, BALABAN D, BRANCH DW, PLOUFFE L : Repeated fetal losses associated with antiphospholipid antibodies : a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992 ; 166 : 1318-23.
35. SILVER RK, MACGREGOR SN, SHOLL JS, HOBART JM, NEERHOF MG, RAGIN A : Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody positive obstetric patients. Am J Obstet Gynecol 1993 ; 169 : 1411-7.
36. KUTTEH WH : Antiphospholipid antibody-associated recurrent pregnancy loss : treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996 ; 174 : 1584-9.